Home The Word Brain | My Amedeo FAQ Privacy About | ||||||||||
The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al. |
Breast Cancer |
Free Subscription
1 Ann Surg |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Breast Cancer is free of charge.
Variability in Medicaid Coverage for Gender-affirming Surgeries Across U.S.
States.
Ann Surg. 2024;279:542-548.
PubMed
Abstract available
Following the High-Risk Patient: Breast Cancer Risk-Based Screening.
Ann Surg Oncol. 2024 Feb 1. doi: 10.1245/s10434-024-14957.
PubMed
Abstract available
A Multi-institutional Analysis of Factors Influencing the Rate of Positive MRI
Biopsy Among Women with Early-Stage Breast Cancer.
Ann Surg Oncol. 2024 Jan 29. doi: 10.1245/s10434-024-14954.
PubMed
Abstract available
Review: Implant-Based Breast Reconstruction After Mastectomy for Breast Cancer: A
Meta-analysis of Randomized Controlled Trials and Prospective Studies Comparing
Use of Acellular Dermal Matrix (ADM) Versus Without ADM.
Ann Surg Oncol. 2024 Jan 29. doi: 10.1245/s10434-024-14943.
PubMed
Abstract available
Disparities in Mortality Trends of Breast Cancer by Racial and Ethnic Status in
the United States.
Anticancer Res. 2024;44:751-755.
PubMed
Abstract available
Cardiovascular health assessment in routine cancer follow-up in community
settings: survivor risk awareness and perspectives.
BMC Cancer. 2024;24:158.
PubMed
Abstract available
Hypoxia-induced miR-181a-5p up-regulation reduces epirubicin sensitivity in
breast cancer cells through inhibiting EPDR1/TRPC1 to activate PI3K/AKT signaling
pathway.
BMC Cancer. 2024;24:167.
PubMed
Abstract available
Unveiling promising breast cancer biomarkers: an integrative approach combining
bioinformatics analysis and experimental verification.
BMC Cancer. 2024;24:155.
PubMed
Abstract available
Transcutaneous canine breast cancer detection in Tunisia: a pilot study.
BMC Cancer. 2024;24:151.
PubMed
Abstract available
A UK prospective multicentre decision impact, decision conflict and economic
evaluation of the 21-gene assay in women with node+ve, hormone receptor+ve,
HER2-ve breast cancer.
Br J Cancer. 2024 Feb 2. doi: 10.1038/s41416-024-02588.
PubMed
Abstract available
Rethinking surgical revisions: impact of the MonarchE trial on axillary
dissection in hormone-positive HER2-negative early breast cancer patients
potentially eligible for abemaciclib.
Br J Cancer. 2024 Jan 27. doi: 10.1038/s41416-024-02580.
PubMed
Abstract available
Neoadjuvant nivolumab plus bevacizumab therapy improves the prognosis of
triple-negative breast cancer in humanized mouse models.
Breast Cancer. 2024 Jan 30. doi: 10.1007/s12282-024-01543.
PubMed
Abstract available
Caveolin-1, a Determinant of the Fate of MCF-7 Breast Cancer Cells.
Breast Cancer (Auckl). 2024;18:11782234241226802.
PubMed
Abstract available
Development and prognostic validation of a three-level NHG-like deep
learning-based model for histological grading of breast cancer.
Breast Cancer Res. 2024;26:17.
PubMed
Abstract available
Development of a machine learning-based radiomics signature for estimating breast
cancer TME phenotypes and predicting anti-PD-1/PD-L1 immunotherapy response.
Breast Cancer Res. 2024;26:18.
PubMed
Abstract available
ADAMTS18 deficiency associates extracellular matrix dysfunction with a higher
risk of HER2-positive mammary tumorigenesis and metastasis.
Breast Cancer Res. 2024;26:19.
PubMed
Abstract available
TBCRC 039: a phase II study of preoperative ruxolitinib with or without
paclitaxel for triple-negative inflammatory breast cancer.
Breast Cancer Res. 2024;26:20.
PubMed
Abstract available
Effect of metformin and lifestyle intervention on adipokines and hormones in
breast cancer survivors: a pooled analysis from two randomized controlled trials.
Breast Cancer Res Treat. 2024 Jan 26. doi: 10.1007/s10549-023-07241.
PubMed
Abstract available
Exploration of MELK as a downstream of Del-1 and druggable targets in
triple-negative breast cancer.
Breast Cancer Res Treat. 2024 Jan 27. doi: 10.1007/s10549-023-07198.
PubMed
Abstract available
Omission of axillary lymph node dissection for breast cancer patients with three
or more positive sentinel lymph nodes.
Breast Cancer Res Treat. 2024 Jan 28. doi: 10.1007/s10549-023-07203.
PubMed
Abstract available
Effects of physical exercise during adjuvant chemotherapy for breast cancer on
long-term tested and perceived cognition: results of a pragmatic follow-up study.
Breast Cancer Res Treat. 2024 Jan 29. doi: 10.1007/s10549-023-07220.
PubMed
Abstract available
High tumor infiltrating lymphocytes are significantly associated with
pathological complete response in triple negative breast cancer treated with
neoadjuvant KEYNOTE-522 chemoimmunotherapy.
Breast Cancer Res Treat. 2024 Jan 30. doi: 10.1007/s10549-023-07233.
PubMed
Abstract available
Trastuzumab and first-line taxane chemotherapy in metastatic breast cancer
patients with a HER2-negative tumor and HER2-positive circulating tumor cells: a
phase II trial.
Breast Cancer Res Treat. 2024 Jan 31. doi: 10.1007/s10549-023-07231.
PubMed
Abstract available
Deep learning-guided adjuvant chemotherapy selection for elderly patients with
breast cancer.
Breast Cancer Res Treat. 2024 Jan 31. doi: 10.1007/s10549-023-07237.
PubMed
Abstract available
Spermatid perinuclear RNA-binding protein promotes UBR5-mediated proteolysis of
Dicer to accelerate triple-negative breast cancer progression.
Cancer Lett. 2024 Jan 25:216672. doi: 10.1016/j.canlet.2024.216672.
PubMed
Abstract available
Inhibition of ATM promotes PD-L1 expression by activating JNK/c-Jun/TNF-alpha
signaling axis in triple-negative breast cancer.
Cancer Lett. 2024 Jan 24:216642. doi: 10.1016/j.canlet.2024.216642.
PubMed
Abstract available
Pre- and Postoperative Antioxidant Use, Aryl Hydrocarbon Receptor (AhR)
Activation and Clinical Outcome in Different Treatment Groups of Breast Cancer
Patients.
Clin Breast Cancer. 2023 Dec 21:S1526-8209(23)00306.
PubMed
Abstract available
Concurrent Use of Statins in Patients Undergoing Curative Intent Treatment for
Triple Negative Breast Cancer: A Systematic Review and Meta-Analysis.
Clin Breast Cancer. 2023 Dec 16:S1526-8209(23)00305.
PubMed
Abstract available
Prediction of Disease-Free Survival in Breast Cancer using Deep Learning with
Ultrasound and Mammography: A Multicenter Study.
Clin Breast Cancer. 2024 Jan 17:S1526-8209(24)00006.
PubMed
Abstract available
Clinical importance of serum miRNA levels in breast cancer patients.
Discov Oncol. 2024;15:19.
PubMed
Abstract available
Construction and in vitro evaluation of pH-sensitive nanoparticles to reverse
drug resistance of breast cancer stem cells.
Discov Oncol. 2024;15:21.
PubMed
Abstract available
RPN1 promotes the proliferation and invasion of breast cancer cells by activating
the PI3K/AKT/mTOR signaling pathway.
Discov Oncol. 2024;15:25.
PubMed
Abstract available
SAA1-dependent reprogramming of adipocytes by tumor cells is associated with
triple negative breast cancer aggressiveness.
Int J Cancer. 2024 Jan 30. doi: 10.1002/ijc.34859.
PubMed
Abstract available
HER2 heterogeneity and treatment response-associated profiles in HER2-positive
breast cancer in the NCT02326974 clinical trial.
J Clin Invest. 2024 Feb 1:e176454. doi: 10.1172/JCI176454.
PubMed
Abstract available
Patient-Reported Outcomes in OlympiA: A Phase III, Randomized, Placebo-Controlled
Trial of Adjuvant Olaparib in gBRCA1/2 Mutations and High-Risk Human Epidermal
Growth Factor Receptor 2-Negative Early Breast Cancer.
J Clin Oncol. 2024 Feb 1:JCO2301214. doi: 10.1200/JCO.23.01214.
PubMed
Abstract available
Simulating the population impact of interventions to reduce racial gaps in breast
cancer treatment.
J Natl Cancer Inst. 2024 Jan 27:djae019. doi: 10.1093.
PubMed
Abstract available
The Current and Future Roles of Precision Oncology in Advanced Breast Cancer.
J Nucl Med. 2024 Feb 1:jnumed.122.264882. doi: 10.2967/jnumed.122.264882.
PubMed
Abstract available
International multidisciplinary consensus on the integration of radiotherapy with
new systemic treatments for breast cancer: European Society for Radiotherapy and
Oncology (ESTRO)-endorsed recommendations.
Lancet Oncol. 2024;25:e73-e83.
PubMed
Abstract available
High B7-H3 expression with low PD-L1 expression identifies armored-cold tumors in
triple-negative breast cancer.
NPJ Breast Cancer. 2024;10:11.
PubMed
Abstract available
Novel exosomal circEGFR facilitates triple negative breast cancer autophagy via
promoting TFEB nuclear trafficking and modulating miR-224-5p/ATG13/ULK1 feedback
loop.
Oncogene. 2024 Jan 27. doi: 10.1038/s41388-024-02950.
PubMed
Abstract available
Blocking LBH expression causes replication stress and sensitizes triple-negative
breast cancer cells to ATR inhibitor treatment.
Oncogene. 2024 Jan 31. doi: 10.1038/s41388-024-02951.
PubMed
Abstract available
Machine learning and bioinformatic analyses link the cell surface receptor
transcript levels to the drug response of breast cancer cells and drug off-target
effects.
PLoS One. 2024;19:e0296511.
PubMed
Abstract available
Survival according to the site of metastasis in triple-negative breast cancer
patients: The Peruvian experience.
PLoS One. 2024;19:e0293833.
PubMed
Abstract available
Evaluating the Use of ChatGPT to Accurately Simplify Patient-centered Information
about Breast Cancer Prevention and Screening.
Radiol Imaging Cancer. 2024;6:e230086.
PubMed
Abstract available
Radiologic-Pathologic Correlation of Nonmass Enhancement Contiguous with
Malignant Index Breast Cancer Masses at Preoperative Breast MRI.
Radiol Imaging Cancer. 2024;6:e230060.
PubMed
Abstract available
Thank you for your interest in scientific medicine.